Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Review ArticleTeaching Case Studies

Favorable Response of Metastatic Merkel Cell Carcinoma to Targeted 177Lu-DOTATATE Therapy: Will PRRT Evolve to Become an Important Approach in Receptor-Positive Cases?

Sandip Basu and Rohit Ranade
Journal of Nuclear Medicine Technology June 2016, 44 (2) 85-87; DOI: https://doi.org/10.2967/jnmt.115.163527
Sandip Basu
Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Mumbai, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rohit Ranade
Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Mumbai, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 44 no. 2 85-87
DOI 
https://doi.org/10.2967/jnmt.115.163527
PubMed 
26471333

Published By 
Society of Nuclear Medicine
Print ISSN 
0091-4916
Online ISSN 
1535-5675
History 
  • Received for publication July 8, 2015
  • Accepted for publication September 2, 2015
  • Published online June 3, 2016.

Article Versions

  • previous version (October 15, 2015 - 07:00).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2016 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Sandip Basu and
  2. Rohit Ranade
  1. Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Mumbai, India
  1. For correspondence or reprints contact: Sandip Basu, Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Jerbai Wadia Rd., Parel, Mumbai, Maharashtra, India, 400 012. E-mail: drsanb{at}yahoo.com
View Full Text

Statistics from Altmetric.com

Cited By...

  • 32 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors
    Sandip Basu, Rahul V. Parghane, Kamaldeep, Sudipta Chakrabarty
    Seminars in Nuclear Medicine 2020 50 5
  • High somatostatin receptor expression and efficacy of somatostatin analogues in patients with metastatic Merkel cell carcinoma*
    T. Akaike, J. Qazi, A. Anderson, F.S. Behnia, M.M. Shinohara, G. Akaike, D.S. Hippe, H. Thomas, S.R. Takagishi, K. Lachance, S.Y. Park, E.S. Tarabadkar, J.G. Iyer, A. Blom, U. Parvathaneni, H. Vesselle, P. Nghiem, S. Bhatia
    British Journal of Dermatology 2021 184 2
  • How We Treat Merkel Cell Carcinoma: Within and Beyond Current Guidelines
    Song Y Park, Coley Doolittle-Amieva, Yasman Moshiri, Tomoko Akaike, Upendra Parvathaneni, Shailender Bhatia, Lisa C Zaba, Paul Nghiem
    Future Oncology 2021 17 11
  • Updates on Merkel Cell Carcinoma
    Drew A. Emge, Adela R. Cardones
    Dermatologic Clinics 2019 37 4
  • 18F-FDG and 68Ga-somatostatin analogs PET/CT in patients with Merkel cell carcinoma: a comparison study
    Silvia Taralli, Martina Sollini, Michele Milella, Germano Perotti, Angelina Filice, Massimo Menga, Annibale Versari, Vittoria Rufini
    EJNMMI Research 2018 8 1
  • Imaging of Merkel Cell Carcinoma: What Imaging Experts Should Know
    Gensuke Akaike, Tomoko Akaike, Shaimaa A. Fadl, Kristina Lachance, Paul Nghiem, Fatemeh Behnia
    RadioGraphics 2019 39 7
  • Merkel Cell Carcinoma: An Immunotherapy Fairy-Tale?
    Enrica Teresa Tanda, Agostina Lagodin d’Amato, Giovanni Rossi, Elena Croce, Andrea Boutros, Federica Cecchi, Francesco Spagnolo, Paola Queirolo
    Frontiers in Oncology 2021 11
  • Current and upcoming radionuclide therapies in the direction of precision oncology: A narrative review
    Hina J. Shah, Evan Ruppell, Rozan Bokhari, Parag Aland, Vikram R. Lele, Connie Ge, Lacey J. McIntosh
    European Journal of Radiology Open 2023 10
  • Advances in Merkel cell carcinoma from a pathologist's perspective
    Sarah Kay Barksdale
    Pathology 2017 49 6
  • Expanding the Indication for Novel Theranostic 177Lu-Dotatate Peptide Receptor Radionuclide Therapy: Proof-of-Concept of PRRT in Merkel Cell Cancer
    Pashtoon M. Kasi, Akash Sharma, Manoj K. Jain
    Case Reports in Oncology 2019 12 1

Article usage

Article usage: October 2015 to April 2025

AbstractFullPdf
Oct 20154102
Nov 201571010
Dec 20153401
Jan 20163803
Feb 20163703
Mar 20163315
Apr 20164301
May 20166100
Jun 2016289622
Jul 20161752024
Aug 20161732622
Sep 20161442321
Oct 20161281518
Nov 20161191221
Dec 2016147859
Jan 2017116105
Feb 201710024
Mar 20175826
Apr 201772222
May 20173729
Jun 2017461715
Jul 2017501829
Aug 201731917
Sep 2017401510
Oct 2017431935
Nov 2017372826
Dec 2017303027
Jan 201854378
Feb 2018332420
Mar 2018363529
Apr 2018312924
May 2018423037
Jun 2018141929
Jul 2018181929
Aug 2018241110
Sep 2018133510
Oct 201817236
Nov 201810229
Dec 2018121711
Jan 2019172310
Feb 2019131048
Mar 20192011027
Apr 2019168215
May 2019107610
Jun 2019116812
Jul 201913695
Aug 201910826
Sep 2019116919
Oct 201914149
Nov 20191631921
Dec 20198913
Jan 202011108
Feb 20209115
Mar 2020231111
Apr 20201467
May 202012511
Jun 20201216
Jul 20202486
Aug 20201399
Sep 20201179
Oct 2020201011
Nov 2020161914
Dec 2020966
Jan 2021569
Feb 202181017
Mar 20211168
Apr 20214208
May 202132314
Jun 20214145
Jul 202171413
Aug 202181522
Sep 202182010
Oct 202191521
Nov 2021112529
Dec 2021102520
Jan 2022101616
Feb 202231916
Mar 202251514
Apr 20225206
May 202222927
Jun 202241220
Jul 20224103
Aug 20227104
Sep 202252316
Oct 20221136
Nov 20223176
Dec 20221218
Jan 20233147
Feb 20232102
Mar 20236156
Apr 20235175
May 20237197
Jun 20232219
Jul 202312149
Aug 202342816
Sep 20237213
Oct 202362213
Nov 202310278
Dec 20234249
Jan 20247308
Feb 20244158
Mar 2024181144
Apr 202482110
May 2024125518
Jun 2024222216
Jul 202491319
Aug 202422022
Sep 2024182322
Oct 202413914
Nov 20247137
Dec 20243109
Jan 202511226
Feb 202554721
Mar 202564826
Apr 2025122432
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 44 (2)
Journal of Nuclear Medicine Technology
Vol. 44, Issue 2
June 1, 2016
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Favorable Response of Metastatic Merkel Cell Carcinoma to Targeted 177Lu-DOTATATE Therapy: Will PRRT Evolve to Become an Important Approach in Receptor-Positive Cases?
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Favorable Response of Metastatic Merkel Cell Carcinoma to Targeted 177Lu-DOTATATE Therapy: Will PRRT Evolve to Become an Important Approach in Receptor-Positive Cases?
Sandip Basu, Rohit Ranade
Journal of Nuclear Medicine Technology Jun 2016, 44 (2) 85-87; DOI: 10.2967/jnmt.115.163527

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Favorable Response of Metastatic Merkel Cell Carcinoma to Targeted 177Lu-DOTATATE Therapy: Will PRRT Evolve to Become an Important Approach in Receptor-Positive Cases?
Sandip Basu, Rohit Ranade
Journal of Nuclear Medicine Technology Jun 2016, 44 (2) 85-87; DOI: 10.2967/jnmt.115.163527
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • CASE REPORT
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Peptide Receptor Radionuclide Therapy in Merkel Cell Carcinoma: A Comprehensive Review
  • Google Scholar

More in this TOC Section

  • High-Sensitivity Troponin Elevation in a Young Woman with Typical Chest Pain: The Heart of the Matter
  • Pulmonary Adenocarcinoma Revealed by Parathyroid Scintigraphy: An Incidental Case to Remember
  • Prominent Right Ventricular Tracer Uptake: A Harbinger of Multivessel Coronary Artery Disease
Show more Teaching Case Studies

Similar Articles

Keywords

  • Merkel cell carcinoma
  • 177Lu-DOTATATE
  • Peptide Receptor Radionuclide Therapy
  • PRRT
SNMMI

© 2025 SNMMI

Powered by HighWire